These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


394 related items for PubMed ID: 16955506

  • 1. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase.
    Ceppi P, Volante M, Saviozzi S, Rapa I, Novello S, Cambieri A, Lo Iacono M, Cappia S, Papotti M, Scagliotti GV.
    Cancer; 2006 Oct 01; 107(7):1589-96. PubMed ID: 16955506
    [Abstract] [Full Text] [Related]

  • 2. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
    Ibe T, Shimizu K, Nakano T, Kakegawa S, Kamiyoshihara M, Nakajima T, Kaira K, Takeyoshi I.
    J Surg Oncol; 2010 Jul 01; 102(1):11-7. PubMed ID: 20578072
    [Abstract] [Full Text] [Related]

  • 3. Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung.
    Hashimoto H, Ozeki Y, Sato M, Obara K, Matsutani N, Nakagishi Y, Ogata T, Maehara T.
    Cancer; 2006 Apr 01; 106(7):1595-601. PubMed ID: 16489621
    [Abstract] [Full Text] [Related]

  • 4. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T, Kondo K, Fujino H, Takahashi Y, Sawada N, Sakiyama S, Tsuyuguchi M, Kimura S, Sumitomo M, Monden Y.
    Anticancer Res; 2005 Apr 01; 25(2A):923-30. PubMed ID: 15868929
    [Abstract] [Full Text] [Related]

  • 5. Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors.
    Ceppi P, Volante M, Ferrero A, Righi L, Rapa I, Rosas R, Berruti A, Dogliotti L, Scagliotti GV, Papotti M.
    Clin Cancer Res; 2008 Feb 15; 14(4):1059-64. PubMed ID: 18281538
    [Abstract] [Full Text] [Related]

  • 6. The discrepancy in thymidylate synthase and dihydropyrimidine dehydrogenase expression depending on measurement methodologies in stage 4 gastric cancer.
    Akamoto S, Usuki H, Haba R, Kakinoki K, Okano K, Izuishi K, Wakabayashi H, Suzuki Y.
    Hepatogastroenterology; 2008 Feb 15; 55(86-87):1882-6. PubMed ID: 19102414
    [Abstract] [Full Text] [Related]

  • 7. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
    Harada K, Kawashima Y, Yoshida H, Sato M.
    Oncol Rep; 2006 Jun 15; 15(6):1417-23. PubMed ID: 16685374
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.
    J Clin Oncol; 2009 Apr 20; 27(12):2030-7. PubMed ID: 19273703
    [Abstract] [Full Text] [Related]

  • 9. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.
    Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L.
    Cancer Res; 1995 Apr 01; 55(7):1407-12. PubMed ID: 7882343
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma.
    Sasaki H, Fukai I, Kiriyama M, Kaji M, Yano M, Yamakawa Y, Fujii Y.
    Surg Today; 2003 Apr 01; 33(2):83-8. PubMed ID: 12616366
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.
    Cancer; 2009 Apr 01; 115(7):1507-17. PubMed ID: 19170237
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K.
    Cancer; 2003 Sep 01; 98(5):1008-13. PubMed ID: 12942569
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
    Hu Z, Xiao T, Lin DM, Guo SP, Zhang ZQ, Di XB, Cheng SJ, Gao YN.
    Zhonghua Zhong Liu Za Zhi; 2007 Aug 01; 29(8):591-5. PubMed ID: 18210878
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR.
    Simi L, Andreani M, Davini F, Janni A, Pazzagli M, Serio M, Orlando C.
    Lung Cancer; 2004 Aug 01; 45(2):171-9. PubMed ID: 15246188
    [Abstract] [Full Text] [Related]

  • 20. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H.
    Clin Cancer Res; 2007 Dec 01; 13(23):6938-46. PubMed ID: 18056168
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.